Jeffrey Karp, PhD

Jeffrey Karp, PhD

Brigham & Women's Hospital
Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology
Jeffrey Karp, PhD

Dr. Jeff Karp is a Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School. He is also a principal faculty member at the Harvard Stem Cell Institute, and an affiliate faculty member at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.

He works in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives. He has published over 125 peer-reviewed papers, with >18,500 citations, and has given over 300 invited lectures. He has over 100 issued or pending national and international patents. Several technologies developed in his lab have led to multiple products currently in development or on the market and for the launch of seven companies that have raised over $300 million in funding. Technologies include hightech skincare, tissue adhesives and 3D printed biomedical devices, immunomodulation with biologically responsive materials, small molecule regenerative therapeutics with an initial target of hearing loss, cannabinoid therapeutics, biomedical devices to improve child safety, needles that automatically stop when they reach their target, and a bioengineered luminal coating for controlled GI targeting.

Karp has received over 50 awards and honors. Boston Magazine recently recognized Karp as one of 11 Boston Doctors Making Medical Breakthroughs. The Boston Business Journal recognized him as a Champion in Healthcare Innovation and MIT’s Technology Review Magazine (TR35) also recognized Karp as being one of the top innovators in the world (three members from his laboratory have subsequently received this award). Karp was elected to the American Institute for Medical and Biological Engineering’s College of Fellows in 2013, a fellow of the Biomedical Engineering Society (BMES) in 2018, and a Fellow of the Royal Society of Chemistry and the Canadian Academy of Engineering in 2019. His work has been selected by Popular Mechanic's as one of the Top 20 New Biotech Breakthroughs that Will Change Medicine. He gave a commencement speech at his high school in 2011, and a TEDMED talk in 2014 at the Kennedy Center in DC on bioinspired medical innovation, and since 2015 has been a member of the TEDMED Editorial Advisory Board. In 2015 and 2016, he received Breakthrough Awards from the Kenneth Rainin Foundation, and in 2015 was a commencement speaker at the University of Toronto Faculty of Dentistry and Pharmacy. His lab has been funded by the NIH, NFL, Bill and Melinda Gates Foundation, Prostate Cancer Foundation, Kenneth Rainin Foundation, JDRF, Helmsley Trust, DoD, Sanofi, J&J, Phillips, Leo Pharma, UCB Pharma. Rheumatology Research Foundation, Coulter Foundation, Brain Science Foundation, American Heart Association, Deshpande Foundation, Institute for Pediatric Innovation, Boston Children’s Hospital, Brigham and Women’s Hospital, the Government of India the Government of Korea, and the Government of Saudi Arabia. Karp also won an internal Shark Tank award judged by Kevin O’Leary (from ABC’s Shark Tank). In 2018 Karp gave a TEDx talk on Radical Simplicity at Boston’s JFK Museum. Furthermore, in 2019 Karp a grade 8 commencement speech at the Talcott Mountain Academy in Connecticut.

In addition to his research goals, Karp is dedicated to developing the careers of the next generation bioengineers at the forefront of regenerative medicine. He was selected as the Outstanding Faculty Undergraduate Mentor among all faculty at MIT and he received the HST McMahon Mentoring award for being the top mentor of Harvard-MIT students. To date, 20 trainees from his laboratory have secured faculty positions.

Karp dedicates significant time to inspiring the next generation through hosting multiple groups of grade school and high school children to his laboratory each year for lectures and hands-on demonstrations, including schools from Japan, Sweden, and France, as well as through lectures at local and national schools.

Contact Information

Research Interest(s)

Year